Author(s): KD Salima, Rajesh Gopalakrishna, Renjitha Bhaskaran, Roshni PR

Email(s): salimasalukd95@gmail.com , grajesh@aims.amrita.edu , renjitha21339@aims.amrita.edu

DOI: 10.5958/0974-360X.2019.00176.8   

Address: KD Salima1, Dr. Rajesh Gopalakrishna2, Renjitha Bhaskaran3, Roshni PR4*
1M Pharm Student, Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala ,India
2Professor, Department of Gastroenterology, Amrita Institute of Medical Sciences and Research Centre, Kochi
3Lecturer, Department of Biostatistics, School of Medicine, Amrita Vishwa Vidyapeetham, Kochi
4Assistant Professor, Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala
*Corresponding Author

Published In:   Volume - 12,      Issue - 3,     Year - 2019


ABSTRACT:
Aim: There are no guidelines for use of diabetic medications in pancreatic diabetes. Hence we attempted to the benefits of antidiabetic agents in pancreatic diabetes. Materials and methods: a total of 670 chronic pancreatitis patients are selected. Out of that about 126 patients with pancreatic diabetic are selected for the study. The data collected from 2010. Results: In this study mean age was found to be 53.86±12.53. The male patients (73.8%) were more predominant in this study than female patients (26.2%). The complications of chronic pancreatitis among 126 patients, 126 (100) patient had diabetes mellitus (DM), 100 (79) patients had pain. Among 126 patients 52 (41.3%) patients had taken insulin only, 21 (16.7%) patients had taken insulin+ oral combination, 16 (12.7%) patients had taken Biguanides, 13 (10.3%) of patients had taken oral combinations, 13 (10.3%) patients had taken alpha glucosidase inhibitors, 11 (8.7%) patients who are taken sulfonyl ureas. Most of the patients took insulin monotherapy. Conclusion: Insulin was most preferred agent. Metformin was the most commonly preferred oral antidiabetic agent.


Cite this article:
KD Salima, Rajesh Gopalakrishna, Renjitha Bhaskaran, Roshni PR. Physician Preference of Anti-diabetic Medications and Complications in Pancreatic Diabetes - An experience from a Tertiary Care Teaching Hospital. Research J. Pharm. and Tech. 2019; 12(3): 1075-1078. doi: 10.5958/0974-360X.2019.00176.8

Cite(Electronic):
KD Salima, Rajesh Gopalakrishna, Renjitha Bhaskaran, Roshni PR. Physician Preference of Anti-diabetic Medications and Complications in Pancreatic Diabetes - An experience from a Tertiary Care Teaching Hospital. Research J. Pharm. and Tech. 2019; 12(3): 1075-1078. doi: 10.5958/0974-360X.2019.00176.8   Available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-3-15


Recomonded Articles:

Author(s): Krithika. R. Iyengar, M. Komala, S. Satheeshkumar

DOI: 10.5958/0974-360X.2020.01089.6         Access: Open Access Read More

Author(s): Bharathi. S

DOI: 10.5958/0974-360X.2015.00188.2         Access: Open Access Read More

Author(s): Sagar D. Kadam, Shashikant Dhole, Sohan Chitlange

DOI: 10.5958/0974-360X.2020.00403.5         Access: Open Access Read More

Author(s): Lakshmi Prasanna J., Deepthi B., Rama Rao N

DOI: Not Available         Access: Open Access Read More

Author(s): Mohammad Ahmed Issa Al-Hatamleh, Omar Mahmoud Al-Shajrawi, SaifUllah Khan, Muhammad Ilyas Nadeem, Nordin Bin Simbak, Ahmad Zubaidi A. Latif, Atif Amin Baig, Tengku Mohammad Ariff

DOI: 10.5958/0974-360X.2018.00711.4         Access: Open Access Read More

Author(s): Nirenjen. S, Praveen. D, Ranadheer Chowdary. P, Vijey Aanandhi. M

DOI: 10.5958/0974-360X.2020.00707.6         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags